Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Bullboard Posts
Comment by iplaygolfon Dec 09, 2017 3:58pm
117 Views
Post# 27124407

RE:RTI versus Isol

RE:RTI versus Isol When u hear grandmothers ask their daughters medical friend to get cbd cream for them in Vancouver you know ISOL Is gonna be big in pharmaceuticals. How many people smoke weed compared to use creams and pills from pharmacies.  Lots of people will grow weed and Government will want cheapest price to sell.  CBD extraction and then formulated into products is expensive and people won’t complain about the price if it works and gets them off pain pills.  Sold all my Aurora and Aphria for gains and am 98% invested in Isol.  Maybe sell some at 10$ but holding the rest to see if gets to GW pharmaceuticals potential (128$ a share) and they DO NOT have a line of products to go along with the drugs they are working on for MS and Epilepsy.
Bullboard Posts